MyFinsight
Home
Blog
About
Back
Cash Flow
Grace Therapeutics, Inc. (GRCE)
Grace Therapeutics, Inc. (GRCE)
source: myfinsight.com
Net decrease in cash
and cash...
-$3,221K
(-51.36%↓ Y/Y)
Impairment of intangible
assets
$13,533K
Stock-based compensation
$105K
(-65.23%↓ Y/Y)
Depreciation expense
$2K
(0.00%↑ Y/Y)
Net cash used in
operating activities
-$3,221K
(-78.85%↓ Y/Y)
Canceled cashflow
$13,640K
Net loss
-$15,790K
(-369.66%↓ Y/Y)
Trade and other
payables
-$897K
(-226.16%↓ Y/Y)
Prepaid expenses
$174K
(270.21%↑ Y/Y)
Back